128
Views
9
CrossRef citations to date
0
Altmetric
Original

Correlates of Receptive and Distributive Needle Sharing Among Injection Drug Users in Kabul, Afghanistan

, , , , , & show all
Pages 91-100 | Published online: 24 Aug 2009

REFERENCES

  • United Nations Office on Drugs and Crime (UNODC). Afghanistan, Opium Survey 2005. Kabul, Afghanistan, 2005.
  • Beyrer C. Human immunodeficiency virus (HIV) infection rates and drug trafficking: Fearful symmetries. Bull Narcotics 2002; 54:103–116.
  • Joint United Nations Program on AIDS (UNAIDS). Report on the Global AIDS Epidemic. Geneva, 2006.
  • United Nations Office on Drugs and Crime (UNODC). Afghanistan Drug Abuse Survey 2005. Kabul, Afghanistan, 2005.
  • Zafar T, Brahmbhatt H, Imam G, ul Hassan S, Strathdee SA. HIV knowledge and risk behaviours among Pakistani and Afghani drug users in Quetta, Pakistan. J Acquir Immune Defic Syndr 2003; 32(4):394–398.
  • Hankins CA, Friedman SR, Zafar T, Strathdee SA. Transmission and prevention of HIV and sexually transmitted infections in war settings: Implications for current and future armed conflicts. AIDS 2002; 16(17):2245–2252.
  • United Nations Office on Drugs and Crime (UNODC). Community Drug Profile #5: An assessment of problem drug use in Kabul city. Kabul, Afghanistan, 2003.
  • Kral AH, Lorvick J, Ciccarone D, Wenger L, Gee L, Martinez A, Edlin BR. HIV prevalence and risk behaviors among men who have sex with men and inject drugs in San Francisco. J Urban Health 2005; 82(1 Suppl 1):i43–50.
  • Booth RE, Kwiatkowski CF, Mikulich-Gilbertson SK, Brewster JT, Salomsen-Sautel S, Corsi KF, Sinitsyna L. Predictors of risky needle use following interventions with injection drug users in Ukraine. Drug Alcohol Depend 2006; 82(Suppl 1):S49–55.
  • Kuo I, Ul-Hasan S, Galai N, Thomas DL, Zafar T, Ahmed MA, Strathdee SA. High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan. Harm Reduct J 2006; 3:26.
  • Grund JP, Friedman SR, Stern LS, Jose B, Neaigus A, Curtis R, Des Jarlais DC. Syringe-mediated drug sharing among injecting drug users: Patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med 1996; 42(5):691–703.
  • Lamothe F, Bruneau J, Coates R, Rankin RJ, Soto J, Arshinoff R, Brabant M, Vincelette A, Fauvel M. Seroprevalence of and risk factors for HIV-1 infection in injection drug users in Montreal and Toronto: A collaborative study. CMAJ 1993; 149(7):945–951.
  • Havens JR, Walker R, Leukefeld CG. Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend 2007; 87(1):98–102.
  • Williams ML, McCurdy SA, Atkinson JS, Kilonzo GP, Leshabari MT, Ross MW. Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users. AIDS Behav 2007; 11(1):137–144.
  • Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs LJ, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers–Connecticut, 1992–1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10(1):82–89.
  • Hutchinson SJ, Taylor A, Goldberg DJ, Gruer L. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990–1994: Implications for control and prevention of blood-borne viruses. Addiction 2000; 95(6):931–940.
  • Vazirian M, Nassirimanesh B, Zamani S, Ono-Kihara M, Kihara M, Ravari SM, Gouya MM. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduct J 2005; 2:19.
  • Zamani S, Kihara M, Gouya MM, , et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 2005; 19:709–716.
  • Zamani S, Kihara M, Gouya M, Vazirian M, Ono-Kihara M, Razzaghi EM, Ichikawa S. Prevalence of HIV Infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr 2006; 42(7):342–346.
  • Latkin C, Mandell W, Vlahov D, Oziemkowska M, Knowlton A, Celentano D. My place, your place, and no place: Behavior settings as a risk factor for HIV-related injection practices of drug users in Baltimore, Maryland. Am J Community Psychol 1994; 22(3):415–430.
  • Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? CMAJ 2001; 165(4):405–410.
  • Haque N, Zafar T, Brahmbhatt H, Imam G, ul Hassan S, Strathdee SA. High-risk sexual behaviours among drug users in Pakistan: Implications for prevention of STDs and HIV/AIDS. Int J STD AIDS 2004; 15(9):601–607.
  • McCurdy SA, Williams ML, Ross MW, Kilonzo GP, Leshabari MT. A theme issue by, for, and about Africa: New injecting practice increases HIV risk among drug users in Tanzania. BMJ 2005; 331(7519):778.
  • Rhodes T, Judd A, Mikhailova L, Sarang A, Khutorskoy M, Platt L, Lowndes CM, Renton A. Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: Maximizing the protective effects of syringe distribution. J Acquir Immune Defic Syndr 2004; 35(3):293–300.
  • Todd CS, Abed A, Strathdee SA, , et al. Prevalence of HIV, Hepatitis C, Hepatitis B, and associated risk behaviors among injection drug users in Kabul, Afghanistan. Accepted for publication, Emerg Inf Dis 2007; 13(9):1327–1331.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.